Sabrina Martucci Johnson
CIK: 0001199102
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
103K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
122K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
64K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
64K shares- - Sep 11, 2026ATAI
AtaiBeckley Inc.
Disposition(D)DirectStock Option
103K shares- - Jun 4, 2026ATAI
AtaiBeckley Inc.
Award(A)DirectStock Option
122K shares- - Feb 18, 2026DARE
Dare Bioscience, Inc.
Award(A)DirectSeries A Convertible Preferred Stock
10.8K shares- - Feb 18, 2026DARE
Dare Bioscience, Inc.
Award(A)DirectCommon Stock Warrant (right to buy)
21.6K shares- - Jan 30, 2026DARE
Dare Bioscience, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
172K shares- - Jun 26, 2025ATAI
ATAI Life Sciences N.V.
Award(A)DirectStock Option
103K shares- - Jan 28, 2025DARE
Dare Bioscience, Inc.
Award(A)DirectEmployee Stock Option (right to buy)
107K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 103,000 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 121,968 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 64,000 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 64,000 | - | - | Direct |
| Sep 11, 2026 | ATAI AtaiBeckley Inc. | Disposition(D) Stock Option | 103,000 | - | - | Direct |
| Jun 4, 2026 | ATAI AtaiBeckley Inc. | Award(A) Stock Option | 121,968 | - | - | Direct |
| Feb 18, 2026 |  DARE Dare Bioscience, Inc. | Award(A) Series A Convertible Preferred Stock | 10,800 | - | - | Direct |
| Feb 18, 2026 | DARE Dare Bioscience, Inc. | Award(A) Common Stock Warrant (right to buy) | 21,600 | - | - | Direct |
| Jan 30, 2026 | DARE Dare Bioscience, Inc. | Award(A) Employee Stock Option (right to buy) | 172,000 | - | - | Direct |
| Jun 26, 2025 | ATAI ATAI Life Sciences N.V. | Award(A) Stock Option | 103,000 | - | - | Direct |
| Jan 28, 2025 | DARE Dare Bioscience, Inc. | Award(A) Employee Stock Option (right to buy) | 107,000 | - | - | Direct |
1-11 of 11 transactions
About JOHNSON SABRINA MARTUCCI
JOHNSON SABRINA MARTUCCI (SEC CIK 0001199102) files insider reports with the SEC as Director of AtaiBeckley Inc. (ATAI), Chef Executive Officer of Dare Bioscience, Inc. (DARE) and Director of ATAI Life Sciences N.V. (ATAI).
Signal8 holds 6 ownership filings by JOHNSON SABRINA MARTUCCI, all Form 4s, filed between Jan 31, 2025 and Sep 11, 2026. Those filings report 11 transactions, from Jan 28, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on JOHNSON SABRINA MARTUCCI's filings is in NEW YORK, NY.
Recent filings by JOHNSON SABRINA MARTUCCI
- Sep 11, 2026: Disposition to issuer transactions of ATAI derivative securities (5 lines, Form 4, code D).
- Jun 4, 2026: Grant or award of ATAI derivative securities (Form 4, code A).
- Feb 18, 2026: Grants or awards of DARE derivative securities (2 lines, Form 4, code A).
- Jan 30, 2026: Grant or award of DARE derivative securities (Form 4, code A).
- Jun 26, 2025: Grant or award of ATAI derivative securities (Form 4, code A).
Other insiders filing for AtaiBeckley Inc. (ATAI)
- Kochendoerfer Gerd, Chief Operating Officer
- Craig Kevin James, Chief Medical Officer
- Johnson Anne Nagengast, Chief Accounting Officer
- Barrett Christopher Ryan Cave
- Short Glenn Frank, Chief Scientific Officer
- Faerm Michael E., Chief Financial Officer